678-312-5000

Find A Doctor

  • View All Doctors
ban_img

Research Excellence at Gwinnett Medical Center 

With a focus on breast, colorectal and lung cancers that affect the highest number of people, our research team provides excellence in clinical research which leads to improvements in clinical care. Our affiliation with the Duke Cancer Network allows access to both cooperative clinical trials, but also access to the entire Alliance network. As a member of the National Cancer Institute’s (NCI) Community Oncology Research Program (NCORP) through our cancer network alliance, our patients have access to clinical trials through the Duke Cancer Network and other industry sponsored trials.

 

Access to Innovative Clinical Trials in Atlanta and the Surrounding Areas 

In addition to research studies at the Cancer Institute at Gwinnett Medical Center, some of the Alliance studies are also provided by Winship Cancer Institute at Emory University. With our clinical trial access through the Alliance, Cancer Institute patients actually receive the same level of care and the exact same protocols of academic medical centers. So our patients are able to stay in Atlanta and the surrounding areas for advanced cancer care.

 

Range of Categories for Clinical Trial Research

To participate in a clinical trial through our affiliation with the Duke Cancer Network, we follow a regimented process with strict eligibility criteria. This not only protects participants, but also allows our research team to stay targeted to a standardized population based on the clinical trial protocols. Through our research, we work in a range of categories of research through access to different trials at the Cancer Institute at Gwinnett Medical Center, including:

  • Treatment: Compare known standard of care treatment to the clinical trial treatment
  • Lifestyle: Compare how lifestyle changes can affect cancer recurrence as we seek evidence to confirm that adopting healthier lifestyles can affect the recurrence of cancer
  • Prevention: Testing of new screening methods to detect cancer sooner for improved early detection methods
  • Observational: We follow patients over time, recording the natural history of a disease and clinical data to determine both positive and negative effects of any issues related to cancer

 

Targeted Therapies Research

As cancer research has developed over time, we now have more research investigations on targeted therapies. Our research team can actually examine tumor tissue and then determine what treatments will be most effective. For example, some of our research is dedicated to new cancer biomarkers and the testing of reliable predictors. If someone qualifies, they may be eligible to participate in the trial based on their tumor type and specific genetic markers. This level of focused research means that if a cancer biomarker, or a substance that indicates the presence of cancer, can be detected sooner, then appropriate steps can be taken while the cancer is in the earlier stages for improved outcomes.

 

For More Information about Cancer Research 

If you have questions about cancer research at the Cancer Institute at Gwinnett Medical Center or would like more information about our affiliation with the Duke Cancer Network, call our research office at 678-312-3834 or complete our convenient online form